A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia
about
A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia
description
2019 nî lūn-bûn
@nan
2019年の論文
@ja
2019年学术文章
@wuu
2019年学术文章
@zh
2019年学术文章
@zh-cn
2019年学术文章
@zh-hans
2019年学术文章
@zh-my
2019年学术文章
@zh-sg
2019年學術文章
@yue
2019年學術文章
@zh-hant
name
A Phase 1B Clinical Study of C ...... ractory Acute Myeloid Leukemia
@en
type
label
A Phase 1B Clinical Study of C ...... ractory Acute Myeloid Leukemia
@en
prefLabel
A Phase 1B Clinical Study of C ...... ractory Acute Myeloid Leukemia
@en
P2093
P356
P1433
P1476
A Phase 1B Clinical Study of C ...... ractory Acute Myeloid Leukemia
@en
P2093
Fatih M Uckun
Gary Schiller
Justin M Watts
Sanjive Qazi
Vuong N Trieu
P356
10.3390/CANCERS12010074
P577
2019-12-26T00:00:00Z